Material costs per dose of penicillin (ZMW and US$ 2012).
收藏NIAID Data Ecosystem2026-03-09 收录
数据链接：
官方服务：
资源简介：
Material costs per dose of penicillin (ZMW and US$ 2012).
应用场景：
创建时间：
2014-12-05
相关数据集
Supplementary materials: Cost–effectiveness and cost–benefit analysis of oliceridine in the treatment of acute pain
These are peer-reviewed supplementary tables for the article ' Cost–effectiveness and cost-benefit analysis of oliceridine in the treatment of acute pain ' published in the Jo
DataCite Commons2026-04-29 更新180
Evaluation of drug utilisation pattern and cost associated with diabetes mellitusType 2 management in Saudi Arabia
Abstract Diabetic mellitus is an emerging disease in Saudi Arabia. In this regard, a cross-sectional retrospective study was conducted to evaluate drug utilization pattern and the cost associated with
DataCite Commons2023-01-07 更新50
Using Penalized Synthetic Controls on Truncated data: A Case Study on Effect of Marijuana Legalization on Direct Payments to Physicians by Opioid Manufacturers
Amid increasing awareness regarding opioid addiction, medical marijuana has emerged as a substitute to opioids for pain management. Concurrently, opioid manufacturers are putting significant research
Taylor & Francis Group2024-11-19 更新40
A cost-effectiveness analysis of second-generation antihistamine 1 receptor blockers and Japanese kampo shoseiryuto for treatment of perennial allergic rhinitis in outpatient settings in Japan
Objectives: Perennial allergic rhinitis (PAR) is common in Japan. Second-generation antihistamines (SGAs) are commonly used for its treatment; however, it remains unclear which SGA is the most cost
DataCite Commons2025-04-01 更新60
Input parameters for the base-case analysis.
Background Expanding the indication of already approved immuno-oncology drugs presents treatment opportunities for patients but also strains healthcare systems. Cost-based pricing models are discussed
NIAID Data Ecosystem50
